Ms. C*, a 53-year-old African American woman living with HIV for almost a decade, inquired about the recently released recommendations for cardiovascular disease prevention among people with HIV (PWH) ...

MURRAY, Utah (ABc4 Utah) – A new study by researchers at Intermountain Health in Salt Lake City aims to determine the best method to screen and evaluate patients who are at risk of developing coronary ...

The 2025-2030 Dietary Guidelines for Americans, released Jan. 7, score well for their streamlined approach, for limiting “bad ...

(HealthDay News) — Guidelines differ on recommendations for statin treatment in African-Americans, according to a study published online in JAMA Cardiology to coincide with the annual meeting of the ...

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of preventive management than in the general population. Last year, an HHS panel ...

The panel favored statins for patients with a 10-year ASCVD risk score below 5%, but recommended patient-clinician risk discussions that accounted for additional HIV-related risk factors that could ...

In an accompanying editorial, Rita F. Redberg, MD, MSc, and Mitchell H. Katz, MD, from the Department of Medicine at the University of California in San Francisco, note that clinicians must verify ...

The target trial emulation study suggests rigid risk thresholds aren’t needed to steer statin use in this group.

Non-statin therapies with proven cardiovascular benefit (including bempedoic acid), taken alone or in combination, are recommended for patients who are unable to take statin therapy to lower LDL-C ...

A new study by researchers at Intermountain Health in Salt Lake City aims to determine the best method to screen and evaluate patients who are at risk of developing coronary heart disease and which ...